West Pharmaceutical Services Profit Margin 2010-2022 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of March 31, 2022 is 23.76%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.672B $2.832B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.676B 20.41
McKesson (MCK) United States $46.288B 13.61
AmerisourceBergen (ABC) United States $29.474B 13.60
Laboratory Of America Holdings (LH) United States $22.247B 9.29
Cooper (COO) United States $15.585B 23.99
Cardinal Health (CAH) United States $14.234B 10.93
CONMED (CNMD) United States $2.863B 29.57
Invacare (IVC) United States $0.048B 0.00